about
Engaging basic scientists in translational research: identifying opportunities, overcoming obstaclesActivation of a novel estrogen receptor, GPER, is cardioprotective in male and female ratsEstrogen receptor activation and cardioprotection in ischemia reperfusion injury.Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in femalesMechanism of cardioprotection: what can we learn from females?Myristoylated methionine sulfoxide reductase A protects the heart from ischemia-reperfusion injury.Matrix modulation and heart failure: new concepts question old beliefs.Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.Estrogen-enhanced gene expression of lipoprotein lipase in heart is antagonized by progesterone.miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusionDynamic changes in matrix metalloprotienase activity within the human myocardial interstitium during myocardial arrest and reperfusion.Myocardial interstitial matrix metalloproteinase activity is altered by mechanical changes in LV load: interaction with the angiotensin type 1 receptor.Matrix metalloproteinase abundance in human myocardial fibroblasts: effects of sustained pharmacologic matrix metalloproteinase inhibition.Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.Differential effects of protein kinase C isoform activation in endothelin-mediated myocyte contractile dysfunction with cardioplegic arrest and reperfusion.Engaging basic scientists in translational researchSelective Targeting of Matrix Metalloproteinase Inhibition in Post-Infarction Myocardial RemodelingMyocardial Infarct Expansion and Matrix Metalloproteinase InhibitionRegion- and Type-Specific Induction of Matrix Metalloproteinases in Post–Myocardial Infarction Remodeling
P50
Q28728428-203C1A92-D7B5-4CE5-B5E3-98DBE72AFB19Q29347039-D75858E1-CEC5-4597-B881-96A9E15E5080Q34447516-D5B6E126-93C3-4B5C-9C32-5119BFBA339EQ35079434-FCFE5620-A8C2-4C40-A1AA-F6327D79B31EQ35166344-CB94925F-4B14-43E2-B424-1C6713BDF196Q35395827-64E7D267-8A4D-4AE1-83B5-0EB76DF241ECQ36110481-11646538-8D90-4C62-BE2C-B9E09265AAAEQ36373665-361FAD52-8A87-4BED-9E52-F401F53681BFQ36415839-89A01AAF-F6B8-4267-8745-9D312712B825Q36923973-BCDB1014-DC09-47FF-8684-29F2A054A96CQ37145499-F1E520BA-C953-427C-8336-90EEDCD6054DQ37146358-211BA184-C7E2-4CE7-BF9D-8A75780CD940Q39715025-C354E06A-5044-4FAE-9061-5EE77025FB24Q44434856-F8CC1C19-0B61-49CF-8A56-49C537B22888Q45283113-C11E935C-285C-421B-A6CE-4F01CD26AFC2Q47845736-B4B34F87-FCFE-490C-B499-1822436258EFQ53609374-1EE5C472-7AD6-476C-81F2-6A6DA8323DF5Q57590657-6E4161F8-9D7C-466A-9596-4198F223DA76Q59651623-475908E6-D08A-423A-96BD-B6445D261154Q59651627-2E41BDA0-E837-46BF-9409-E70BEFD48871Q59651629-D763F983-FD27-4207-B115-259D420176F4
P50
description
Senior Science Policy Analyst
@en
wetenschapper
@nl
name
Anne Deschamps
@ast
Anne Deschamps
@en
Anne Deschamps
@es
Anne Deschamps
@nl
type
label
Anne Deschamps
@ast
Anne Deschamps
@en
Anne Deschamps
@es
Anne Deschamps
@nl
prefLabel
Anne Deschamps
@ast
Anne Deschamps
@en
Anne Deschamps
@es
Anne Deschamps
@nl
P106
P1153
7006509148
P21
P31
P496
0000-0001-7415-1408